title: Inhibition of peroxidase and catalase activities and modulation of hydrogen peroxide level by inositol phosphoglycan-like compounds.
abstract: Inositol phosphoglycan-like compounds are produced by the hydrolysis of the membrane bound glycosyl phosphoinositides. Besides being short term mediators of insulin action, they inhibit peroxidases and catalase, increasing the concentration of cellular hydrogen peroxide. Although high concentrations of hydrogen peroxide are toxic, moderate increases of its basal level are signals for different metabolic pathways. The inhibitor, localized in the cytosol of the cell, acts on peroxidases and catalase of the same tissue (homologous action) and of other tissues or organisms (heterologous action). The inositol phosphoglycan-like compound inhibits peroxidases with different prosthetic groups, i.e. containing iron such as: thyroid peroxidase, lactoperoxidase, horseradish peroxidase, soy bean peroxidase; and containing selenium such as glutathione peroxidase and 2-cys peroxiredoxin with no prosthetic group. Besides peroxidases, the inositol phosphoglycan-like compound inhibits catalase, another heme enzyme. The inhibition kinetics demonstrates a noncompetitive effect. The site of action is not the prosthetic group, given that the inhibitor does not produce any effect on the peak in the Soret region in the presence or absence of hydrogen peroxide. In conclusion, the inositol phosphoglycan-like compound is the general inhibitor of peroxidases and catalase involved in the modulation of hydrogen peroxide level that acts in different metabolic pathways as a signal transducer.
authors.affiliation: Department of Radiobiology, Argentine Atomic Energy Commission (CNEA), Buenos Aires, Argentina.
authors.forename: L
authors.initials: L
authors.lastname: Thomasz
authors.forename: M
authors.initials: M
authors.lastname: Aran
authors.forename: R A
authors.initials: RA
authors.lastname: Pizarro
authors.forename: J
authors.initials: J
authors.lastname: Ibañez
authors.forename: M A
authors.initials: MA
authors.lastname: Pisarev
authors.forename: D
authors.initials: D
authors.lastname: Converso
authors.forename: G J
authors.initials: GJ
authors.lastname: Juvenal
authors.forename: L
authors.initials: L
authors.lastname: Krawiec
mesh_terms: D000818:Animals; D002374:Catalase / Q000037:antagonists & inhibitors*; D002417:Cattle; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006735:Horseradish Peroxidase / Q000037:antagonists & inhibitors; D006861:Hydrogen Peroxide / Q000378:metabolism*; D007295:Inositol Phosphates / Q000494:pharmacology*; D007453:Iodide Peroxidase / Q000037:antagonists & inhibitors; D007784:Lactoperoxidase / Q000037:antagonists & inhibitors; D009195:Peroxidase / Q000037:antagonists & inhibitors*; D011134:Polysaccharides / Q000494:pharmacology*; D030262:Soybean Proteins / Q000037:antagonists & inhibitors; D013025:Glycine max / Q000201:enzymology
chemical_list: D004791:Enzyme Inhibitors; D007295:Inositol Phosphates; D011134:Polysaccharides; D030262:Soybean Proteins; C028039:inositol phosphate glycan; D006861:Hydrogen Peroxide; D006735:Horseradish Peroxidase; D007784:Lactoperoxidase; D002374:Catalase; D009195:Peroxidase; D007453:Iodide Peroxidase